VAIA
MLAB icon

Virtus Alternative Investment Advisers’s Mesa Laboratories MLAB Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24
Closed -$7K – 139
2020
Q4 		$7K Sell
24
-23
-49% -$6.33K 0.1% 133
2020
Q3 		$12K Sell
47
-8
-15% -$1.9K 0.22% 60
2020
Q2 		$12K Buy
+55
New +$12.7K 0.19% 238

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Virtus Alternative Investment Advisers's MLAB Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Mesa Laboratories (MLAB) in Q1 2021, closing a stake of 24 shares — an estimated $7K sold.

Virtus Alternative Investment Advisers first reported a position in MLAB in Q2 2020 and held it in 3 quarters. The position peaked at $12K in Q3 2020. 173 funds tracked by Wall St. Rank hold MLAB as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Mesa Laboratories position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 24 Mesa Laboratories shares in Q1 2021, an estimated $7K.
  • Virtus Alternative Investment Advisers first reported a position in Mesa Laboratories in Q2 2020 and held it in 3 quarters.
  • Virtus Alternative Investment Advisers's Mesa Laboratories position peaked at $12K in Q3 2020.
  • 173 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.